SUMMARY A preterm infant with classic phenylketonuria required rather less than 90 mg/kg of phenylalanine and between 270 and 290 mg/kg tyrosine daily to achieve a rate of weight gain of around 20 g/kg per day. Using Lofenalac as the low phenylalanine food, the intake of tyrosine, an essential amino acid for patients with phenylketonuria seemed to be limiting in respect of growth.
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In childhood, growth is the major determinant of protein requirement, which may be defined as the protein intake needed to maintain optimal growth and plasma amino acid concentrations. For preterm infants a guide to optimal growth and plasma amino acid concentrations is given by the average weight gain in utero 2 (with allowance for catch up growth where appropriate) and the amino acid pattern in cord blood, which, apart from a fall in threonine and lysine after birth, closely resembles the pattern found in breast fed infants. tmol/I (2-9 to 7-9 mg/100 ml). The rate of weight gain increased immediately at the start of the diet and weight rose parallel to the 10th centile for a period of seven days. On a daily phenylalanine intake of 100 mg/kg and tyrosine intake of 170 mg/kg plasma phenylalanine fell to normal (lowest value 45 Imol/I (0.7 mg/100 ml)) and plasma tyrosine fell step-wise to below normal (lowest value 29 [imoUl (0.5 mg/100 ml)). On the day that the plasma tyrosine concentration was lowest, and in the absence of any changes in nutritional intake, weight gain declined to the rate before the diet suggesting that tyrosine had become limiting for growth. The initial impression of a parallel relation between plasma tyrosine concentrations and weight gain were confirmed over the next few weeks. (Fig.  2) . Only when the daily tyrosine intake was raised to between 270 and 290 mg/kg per day did plasma tyrosine concentrations rise to the normal range, and from this time on weight gain was over 20 g/kg/day until weight reached the 10th centile at 54 days of age. Changes in length followed the same pattern as changes in weight.
Lofenelac contains 54 mg of tyrosine per 16 g of nitrogen, a very similar proportion to that in SMA Gold Cap and a little more than is in cows' milk (48 mg/16 g nitrogen). To achieve a tyrosine intake of over 200 mg/kg per day it was necessary to increase the total protein intake to over 5 g/kg per day. To avoid an excessive fluid and energy intake this was eventually provided (Fig. 1) 
Discussion
The poor growth recorded in the present patient when receiving pooled human milk is in accord with previous observations.67 An energy intake lower than theoretical estimates may have been the primary cause of the growth impairment and the prompt increase in the rate of weight gain on the diet, despite aiming to keep protein, energy, and mineral intake constant, supports this view. It should be emphasised, however, that simple addition of energy without protein, which is a common practice in special care units, could convert a balanced amino acid intake into one too low to sustain an increased rate of growth.
The rate of weight gain in our patient was closely linked to tyrosine intake and plasma tyrosine concentrations, suggesting that tyrosine intake was rate-limiting for growth. Tyrosine is an essential amino acid for children with phenylketonuria and Lofenalac contains only 54 mg of tyrosine/16 g of nitrogen (N), which is similar to the tyrosine content of Gold Cap SMA and lower than the tyrosine content of Minafen (65 mg/16 g N). Hence to achieve an optimal tyrosine intake for growth from Lofenalac, it was necessary to increase total protein intake to over 5 glkglday. The amino acid imbalance which this caused was clearly related to the amino acid pattern of the feeds since both cows' milk and Lofenalac are low in cystine and taurine and relatively high in methionine and branched-chain amino acids. We suggest that the tyrosine content of Lofenalac should be increased by at least 20% to enable it to be used with whey based milks, thus avoiding an unnecessarily high protein intake and unbalanced amino acid intake.
The data presented here show that when our patient was growing at 20 g/kg/per day, which was necessary to achieve catch up growth, she required rather less than 90 mg/kg of phenylalanine and between 270 and 290 mg/kg of tyrosine. In infants without phenylketonuria, who are able to convert phenylalanine to tyrosine, the requirements for these two amino acids are best considered together. We conclude that a combined intake of at least 350 mg/kg, necessitating a protein intake of 3-5 to 4 g/kg from a whey adapted milk, is required for catch up growth in preterm infants. This estimate is in agreement with other studies.6 7 It has been pointed out that the volumes of milks such as Gold Cap SMA needed to achieve such protein intakes are needlessly high and could be avoided by using milks of higher protein content. We would add that the energy intake provided by large volumes of SMA is also high and may lead to reluctance to feed (and therefore prolonged tube feeding) and excessive fat deposition. 
Case history
The baby was admitted to hospital at 10 weeks of age having become jaundiced over a 24 hour period. She was passing dark urine and pale stools. She had been born after a normal delivery at 36 weeks' gestation, and weighed 2-5 kg. Apart from an episode of transient tachypnoea during the first 48 hours of life, the neonatal period was uneventful. Both parents were Caucasian, there was no history of contact with blood products or drug addiction, and the mother had remained well throughout her pregnancy. The baby had not been exposed to hepatitis nor had she received any blood transfusions.
On examination she was pale and slightly icteric. Investigations showed blood sugar 1-3 mmol/l (23.4 mg/100 ml); prothrombin time greater than 90 seconds (control 11-5 seconds); kaolin cephalin time greater than 3 minutes (control 42 seconds); haemoglobin 9-8 g/dl, reticulocytes 5%, fibrinogen nil detected; total serum bilirubin 268 mmol/l (15-7 mg/100 ml) (all unconjugated); alkaline phosphatase 170 KA units %, aspartate transaminase 113 IU/1,
